Literature DB >> 28329184

The Causal Effect of Tracing by Peer Health Workers on Return to Clinic Among Patients Who Were Lost to Follow-up From Antiretroviral Therapy in Eastern Africa: A "Natural Experiment" Arising From Surveillance of Lost Patients.

Anna Bershetyn1, Thomas A Odeny2, Rita Lyamuya3, Alice Nakiwogga-Muwanga4, Lameck Diero5, Mwebesa Bwana6,7, Paula Braitstein5, Geoffrey Somi3, Andrew Kambugu4, Elizabeth Bukusi2, Wendy Hartogensis8, David V Glidden6, Kara Wools-Kaloustian9, Constantin Yiannoutsos10, Jeffrey Martin6,8, Elvin H Geng8.   

Abstract

BACKGROUND.: The effect of tracing human immunodeficiency virus (HIV)-infected patients who are lost to follow-up (LTFU) on reengagement has not been rigorously assessed. We carried out an ex post analysis of a surveillance study in which LTFU patients were randomly selected for tracing to identify the effect of tracing on reengagement. METHODS.: We evaluated HIV-infected adults on antiretroviral therapy who were LTFU (>90 days late for last visit) at 14 clinics in Uganda, Kenya, and Tanzania. A random sample of LTFU patients was selected for tracing by peer health workers. We assessed the effect of selection for tracing using Kaplan-Meier estimates of reengagement among all patients as well as the subset of LTFU patients who were alive, contacted in person by the tracer, and out of care. RESULTS.: Of 5781 eligible patients, 991 (17%) were randomly selected for tracing. One year after selection for tracing, 13.3% (95% confidence interval [CI], 11.1%-15.3%) of those selected for tracing returned compared with 10.0% (95% CI, 9.1%-10.8%) of those not randomly selected, an adjusted risk difference of 3.0% (95% CI, .7%-5.3%). Among patients found to be alive, personally contacted, and out of care, tracing increased the absolute probability of return at 1 year by 22% (95% CI, 7.1%-36.2%). The effect of tracing on rate of return to clinic decayed with a half-life of 7.0 days after tracing (95% CI, 2.6 %-12.9%). CONCLUSIONS.: Tracing interventions increase reengagement, but developing methods for targeting LTFU patients most likely to benefit can make this practice more efficient.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Africa; antiretroviral therapy; loss to follow-up.; retention

Mesh:

Substances:

Year:  2017        PMID: 28329184      PMCID: PMC5848300          DOI: 10.1093/cid/cix191

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  12 in total

1.  Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.

Authors:  Jean B Nachega; Richard E Chaisson; Rene Goliath; Anne Efron; Mohammad A Chaudhary; Malathi Ram; Chelsea Morroni; Hennie Schoeman; Amy R Knowlton; Gary Maartens
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

2.  GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda.

Authors:  Mark J Siedner; Alexander Lankowski; Alexander C Tsai; Conrad Muzoora; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; David R Bangsberg
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

Review 3.  Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.

Authors:  Alexander J Lankowski; Mark J Siedner; David R Bangsberg; Alexander C Tsai
Journal:  AIDS Behav       Date:  2014-07

4.  Commentary: how to report instrumental variable analyses (suggestions welcome).

Authors:  Sonja A Swanson; Miguel A Hernán
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

5.  Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.

Authors:  Elvin H Geng; Mwebesa B Bwana; Winnie Muyindike; David V Glidden; David R Bangsberg; Torsten B Neilands; Ingrid Bernheimer; Nicolas Musinguzi; Constantin T Yiannoutsos; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

Review 6.  Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.

Authors:  James H McMahon; Julian H Elliott; Steven Y Hong; Silvia Bertagnolio; Michael R Jordan
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

7.  A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

Authors:  Michael H Chung; Barbra A Richardson; Kenneth Tapia; Sarah Benki-Nugent; James N Kiarie; Jane M Simoni; Julie Overbaugh; Mena Attwa; Grace C John-Stewart
Journal:  PLoS Med       Date:  2011-03-01       Impact factor: 11.069

8.  Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs.

Authors:  Mark J Siedner; Alexander Lankowski; Jessica E Haberer; Annet Kembabazi; Nneka Emenyonu; Alexander C Tsai; Conrad Muzoora; Elvin Geng; Jeffrey N Martin; David R Bangsberg
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

9.  Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study.

Authors:  David M Tuller; David R Bangsberg; Jude Senkungu; Norma C Ware; Nneka Emenyonu; Sheri D Weiser
Journal:  AIDS Behav       Date:  2009-03-13

10.  Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study.

Authors:  Norma C Ware; Monique A Wyatt; Elvin H Geng; Sylvia F Kaaya; Oche O Agbaji; Winnie R Muyindike; Guerino Chalamilla; Patricia A Agaba
Journal:  PLoS Med       Date:  2013-01-08       Impact factor: 11.069

View more
  11 in total

1.  Urgent need to improve programmatic management of patients with HIV failing first-line antiretroviral therapy.

Authors:  H Sunpath; T J Hatlen; M-Y S Moosa; R A Murphy; M Siedner; K Naidoo
Journal:  Public Health Action       Date:  2020-12-21

2.  Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.

Authors:  Andrew D Kerkhoff; Kombatende Sikombe; Ingrid Eshun-Wilson; Izukanji Sikazwe; David V Glidden; Jake M Pry; Paul Somwe; Laura K Beres; Sandra Simbeza; Chanda Mwamba; Chama Bukankala; Cardinal Hantuba; Carolyn Bolton Moore; Charles B Holmes; Nancy Padian; Elvin H Geng
Journal:  PLoS Med       Date:  2020-05-13       Impact factor: 11.069

3.  Results from a proactive follow-up intervention to improve linkage and retention among people living with HIV in Uganda: a pre-/post- study.

Authors:  Caroline E Boeke; Vennie Nabitaka; Andrea Rowan; Katherine Guerra; Pamela Nawaggi; Vivienne Mulema; Victor Bigira; Eleanor Magongo; Patricia Mucheri; Andrew Musoke; Cordelia Katureebe
Journal:  BMC Health Serv Res       Date:  2018-12-06       Impact factor: 2.655

4.  Implementation and applications of EMOD, an individual-based multi-disease modeling platform.

Authors:  Anna Bershteyn; Jaline Gerardin; Daniel Bridenbecker; Christopher W Lorton; Jonathan Bloedow; Robert S Baker; Guillaume Chabot-Couture; Ye Chen; Thomas Fischle; Kurt Frey; Jillian S Gauld; Hao Hu; Amanda S Izzo; Daniel J Klein; Dejan Lukacevic; Kevin A McCarthy; Joel C Miller; Andre Lin Ouedraogo; T Alex Perkins; Jeffrey Steinkraus; Quirine A Ten Bosch; Hung-Fu Ting; Svetlana Titova; Bradley G Wagner; Philip A Welkhoff; Edward A Wenger; Christian N Wiswell
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

5.  HIV Care for Patients With Complex Needs: A Controlled Evaluation of a Walk-In, Incentivized Care Model.

Authors:  Julia C Dombrowski; Sean R Galagan; Meena Ramchandani; Shireesha Dhanireddy; Robert D Harrington; Allison Moore; Katie Hara; Mckenna Eastment; Matthew R Golden
Journal:  Open Forum Infect Dis       Date:  2019-06-26       Impact factor: 3.835

6.  Challenges with tracing patients on antiretroviral therapy who are late for clinic appointments in rural South Africa and recommendations for future practice.

Authors:  David Etoori; Alison Wringe; Jenny Renju; Chodziwadziwa Whiteson Kabudula; Francesc Xavier Gomez-Olive; Georges Reniers
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640

7.  Mortality Rate in a Cohort of People Living With HIV in Rural Tanzania After Accounting for Unseen Deaths Among Those Lost to Follow-up.

Authors:  Fiona Vanobberghen; Maja Weisser; Bryson Kasuga; Andrew Katende; Manuel Battegay; Marcel Tanner; Tracy R Glass On Behalf Of The Kiularco Study Group
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897

8.  "I just keep quiet about it and act as if everything is alright" - The cascade from trauma to disengagement among adolescents living with HIV in western Kenya.

Authors:  Leslie A Enane; Edith Apondi; Mark Omollo; Judith J Toromo; Salim Bakari; Josephine Aluoch; Clemette Morris; Rami Kantor; Paula Braitstein; J Dennis Fortenberry; Winstone M Nyandiko; Kara Wools-Kaloustian; Batya Elul; Rachel C Vreeman
Journal:  J Int AIDS Soc       Date:  2021-04       Impact factor: 6.707

9.  An analysis of the HIV testing cascade of a group of HIV-exposed infants from birth to 18 months in peri-urban Khayelitsha, South Africa.

Authors:  Aurelie Kennedy Nelson; Tali Cassidy; Laura Trivino Duran; Vivian Cox; Catherine J Wedderburn; Janet Giddy; Pauline Pieters; Mark F Cotton; Tabitha Mutseyekwa; Bulelwa Rorwana; Beryl Sibanda; Jonathan Bernheimer; Nopinky Matise; Petros Isaakidis; Jean Maritz
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

Review 10.  A Cascade of Interventions to Promote Adherence to Antiretroviral Therapy in African Countries.

Authors:  Rebecca Jopling; Primrose Nyamayaro; Lena S Andersen; Ashraf Kagee; Jessica E Haberer; Melanie Amna Abas
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.